Stem cell-based hepatic differentiation for cell therapy of liver diseases

Su Yeon An, Jiyou Han, Jong-Hoon Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Alternative liver disease treatment has been intensively studied because of the shortage of donated organs for transplantation and difficulty in culturing primary human hepatocytes for cell therapy. Human hepatocytes generated from pluripotent stem cells evolved as a promising treatment for liver disease as a means to overcome these limitations. Recently, embryonic stem cells (ESCs) and adult stem cells have been successfully differentiated into hepatocyte-like cells in vitro. However, it is difficult to compare the results of previous studies because of multiple paths of differentiation using many different standards, protocols, and animal models. Additionally, these cells are required to examine their functionality, their liver regenerating mechanism after appropriate animal models of liver disease prior to clinical trials. In this review paper, we summarize a variety of stem cells and their individual characteristics, which provide multiple opportunities for cell therapy treatment of liver disease patients. Furthermore, we present the current standard of applicable preclinical hepatocytes derived from stem cells such as experimental indicators for differentiation in vitro, confirmation of survival, engraftment, and function after cell transplantation into various preclinical liver disease animal models.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalTissue Engineering and Regenerative Medicine
Volume7
Issue number1
Publication statusPublished - 2010 Jan 1

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Liver
Liver Diseases
Hepatocytes
Stem Cells
Animal Models
Animals
Pluripotent Stem Cells
Adult Stem Cells
Cell Transplantation
Organ Transplantation
Embryonic Stem Cells
Therapeutics
Clinical Trials
Survival
In Vitro Techniques

Keywords

  • Cell therapy
  • Hepatic differentiation
  • Liver diseases jhkim@korea.ac.kr
  • Stem cell

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Stem cell-based hepatic differentiation for cell therapy of liver diseases. / An, Su Yeon; Han, Jiyou; Kim, Jong-Hoon.

In: Tissue Engineering and Regenerative Medicine, Vol. 7, No. 1, 01.01.2010, p. 1-8.

Research output: Contribution to journalArticle

@article{1fe9f32ca5e24864baeb2c72ee125d6f,
title = "Stem cell-based hepatic differentiation for cell therapy of liver diseases",
abstract = "Alternative liver disease treatment has been intensively studied because of the shortage of donated organs for transplantation and difficulty in culturing primary human hepatocytes for cell therapy. Human hepatocytes generated from pluripotent stem cells evolved as a promising treatment for liver disease as a means to overcome these limitations. Recently, embryonic stem cells (ESCs) and adult stem cells have been successfully differentiated into hepatocyte-like cells in vitro. However, it is difficult to compare the results of previous studies because of multiple paths of differentiation using many different standards, protocols, and animal models. Additionally, these cells are required to examine their functionality, their liver regenerating mechanism after appropriate animal models of liver disease prior to clinical trials. In this review paper, we summarize a variety of stem cells and their individual characteristics, which provide multiple opportunities for cell therapy treatment of liver disease patients. Furthermore, we present the current standard of applicable preclinical hepatocytes derived from stem cells such as experimental indicators for differentiation in vitro, confirmation of survival, engraftment, and function after cell transplantation into various preclinical liver disease animal models.",
keywords = "Cell therapy, Hepatic differentiation, Liver diseases jhkim@korea.ac.kr, Stem cell",
author = "An, {Su Yeon} and Jiyou Han and Jong-Hoon Kim",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "1--8",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "1",

}

TY - JOUR

T1 - Stem cell-based hepatic differentiation for cell therapy of liver diseases

AU - An, Su Yeon

AU - Han, Jiyou

AU - Kim, Jong-Hoon

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Alternative liver disease treatment has been intensively studied because of the shortage of donated organs for transplantation and difficulty in culturing primary human hepatocytes for cell therapy. Human hepatocytes generated from pluripotent stem cells evolved as a promising treatment for liver disease as a means to overcome these limitations. Recently, embryonic stem cells (ESCs) and adult stem cells have been successfully differentiated into hepatocyte-like cells in vitro. However, it is difficult to compare the results of previous studies because of multiple paths of differentiation using many different standards, protocols, and animal models. Additionally, these cells are required to examine their functionality, their liver regenerating mechanism after appropriate animal models of liver disease prior to clinical trials. In this review paper, we summarize a variety of stem cells and their individual characteristics, which provide multiple opportunities for cell therapy treatment of liver disease patients. Furthermore, we present the current standard of applicable preclinical hepatocytes derived from stem cells such as experimental indicators for differentiation in vitro, confirmation of survival, engraftment, and function after cell transplantation into various preclinical liver disease animal models.

AB - Alternative liver disease treatment has been intensively studied because of the shortage of donated organs for transplantation and difficulty in culturing primary human hepatocytes for cell therapy. Human hepatocytes generated from pluripotent stem cells evolved as a promising treatment for liver disease as a means to overcome these limitations. Recently, embryonic stem cells (ESCs) and adult stem cells have been successfully differentiated into hepatocyte-like cells in vitro. However, it is difficult to compare the results of previous studies because of multiple paths of differentiation using many different standards, protocols, and animal models. Additionally, these cells are required to examine their functionality, their liver regenerating mechanism after appropriate animal models of liver disease prior to clinical trials. In this review paper, we summarize a variety of stem cells and their individual characteristics, which provide multiple opportunities for cell therapy treatment of liver disease patients. Furthermore, we present the current standard of applicable preclinical hepatocytes derived from stem cells such as experimental indicators for differentiation in vitro, confirmation of survival, engraftment, and function after cell transplantation into various preclinical liver disease animal models.

KW - Cell therapy

KW - Hepatic differentiation

KW - Liver diseases jhkim@korea.ac.kr

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=84884537795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884537795&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84884537795

VL - 7

SP - 1

EP - 8

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 1

ER -